you are here:

Fresenius Kabi Oncology Ltd.

BSE: 532545 | NSE: FKONCO | Series: NA | ISIN: INE575G01010 | SECTOR: Pharmaceuticals

BSE Live

Jan 02, 15:50
132.45 0.00 (0.00%)
Volume
No Data Available
91,518
  • Prev. Close

    132.45

  • Open Price

    132.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    132.45 (20430)

Fresenius Kabi Oncology is not traded on BSE in the last 30 days

NSE Live

Nov 17, 15:16
1348.00 0.00 (0.00%)
Volume
No Data Available
1,345
  • Prev. Close

    1348.00

  • Open Price

    1343.88

  • Bid Price (Qty.)

    1348.00 (4)

  • Offer Price (Qty.)

    1351.46 (1)

Fresenius Kabi Oncology is not traded on NSE in the last 30 days

Annual Report

For Year :
2013 2012 2011 2010 2009 2008 2007

Director’s Report

Your Directors have pleasure in presenting the fourth Annual Report on the business and operations of the Company together with the Audited Accounts for the financial year ended 31st March, 2007. Turnover(including other income) 32828 27398 Profit Before Tax 2991 2232 Less: Provision for Taxation (current) 421 275 Provision for Taxation (deferred) 44 102 Prof it after Tax 2525 1854 Add:,Balance of Profit brought forward from previous year 4278 3029 Profit available for appropriation 6804 4884 Appropriation to: Proposed dividend NIL 312 Corporate tax on proposed dividend NIL 43 General Reserve 300 250 Balance Carried over to the Balance Sheet 6504 4278 Dividend In view of global expansion plans of the Company, your Directors are of the view that profits should be ploughed back in the business and hence have decided not to declare any dividend for the year 2006-07. Business Performance and Operations Kindly refer to Management Discussion & Analysis covered under Corporate Governance, which forms part of this Report. Share Capital The Companys shares continue to be listed on the National Stock Exchange and Bombay Stock Exchange and are actively traded. Following shares were allotted (on pari- passu basis) pursuant to exercise of stock options by the eligible employees of the Company under ESOP Plan of the Company; O1,68,775 equity shares allotted by the Company on 10th October, 2006 O1,26,376 eguity shares allotted by the Company on 5th February, 2007 O2,91,086 equity shares allotted by the Company on 29th March, 2007 Employees Stock Option Plan, 2004 In terms of your Companys ESOP Plan 2004, your Company has allotted 5,86,237 equity shares to eligible employee applicants, including one Wholetime Director, upon vesting of ESOPs granted in 2004-05 and 2005-06 at Re.1/- per share in accordance with the ESOP 2004 plan. The new equity shares have since been listed on NSE and the BSE. As of 31st March, 2007, 4,20,296 ESOPs remained outstanding. Information regarding ESOPs form part of this Report. Corporate Governance Your Company has already implemented the Code of Conduct as required under Clause 49 of the Listing Agreement with Stock Exchanges. A declaration to the effect that the Directors and Senior Managerial Personnel have adhered to the same, signed by the Chief Executive Officer of the Company, forms part of the Corporate Governance Report, which along with Auditors certificate on its compliance, is attached as Annexure to this Report. Directors Mr. Ashok Vij, a Chartered Accountant in Practice was appointed as an Additional Director of the Company effective 23rd January, 2007. He holds the office till the ensuing Annual General Meeting. Notice has been received from a member of the Company, along with necessary deposit of money signifying his intention to propose candidature of Mr. Ashok Vij for the office of Director under Section 257 of the Companies Act, 1956. Mr. Vij is qualifying as Independent Director. As per the provisions contained in the Companies Act, 1956 and the Articles of Association of the Company, Dr. Anand Burman, Chairman and Promoter Director, Mr. P D Narang, Non Executive Independent Director and Dr. Naresh Trehan, Non Executive Independent Director, retire by rotation as Directors and being eligible, have offered themselves for re-election at the ensuing Annual General Meeting. The brief resume / details relating to directors seeking appointment / re-appointment are furnished in the explanatory statement to the notice of the ensuing Annual General Meeting. Directors Responsibility Statement In terms of provisions of Section 217(2AA) of the Companies Act, 1956, the Directors confirm: i) That in the preparation of the annual accounts, the applicable accounting standards have been followed and no material departures have been made from the same; ii) That they had selected such accounting policies and applied them consistently and made judgements and estimates that are reasonable and prudent so as to give true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period; hi) That they had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 1956 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities; iv) That they had prepared the annual accounts on a going concern basis. The Chief Executive Officer (Wholetime Director) and the Chief Financial Officer of the Company have certified to the Board, in the manner required under the Corporate Governance Code, concerning the annual financial statement. Auditors M/s G. Basu & Co., Chartered Accountants and M/s HLB Vantis Audit Plc., London, were respectively appointed as the Statutory Auditors and Branch Auditors of the Company at the last Annual General Meeting held on 14th July, 2006. They shall hold office till the conclusion of the ensuing Annual General Meeting of the Company. M/s G. Basu & Co. have also given a certificate that, if re-appointed for the financial year 2007 - 08, their re-appointment shall be within the statutory limits prescribed under the Companies Act, 1956. The Board of Directors of your Company, recommend their re-appointment. The Directors also propose M/s HLB Vantis Audit Plc., London, for their re-appointment as the Branch Auditors of London Branch of the Company to hold office from conclusion of the ensuing Annual General Meeting till the conclusion of the next Annual General Meeting of the Company. M/s Ramnath Iyer & Co., Cost Accountants were re-appointed as Cost Auditors to conduct cost audit of the accounts maintained by the Company in terms of its formulations for the financial year 2007-08. Consolidated Financial Statements Consolidated Financial Statements for the year ended 31st March, 2007 form part of the Annual Report. Subsidiary As required under the provisions of Section 212 of the Companies Act, 1956, the Audited Accounts together with Directors Report and Auditors Report of the Wholly Owned Foreign Subsidiaries namely Dabur Oncology Plc., UK and Dabur Pharma (Thailand) Co. Ltd., made out in accordance with the requirements of the Companies Act, 1956, are appended to and form part of the Annual Report. The statement pursuant to Section 212 of the Companies Act, 1956 is attached and forms part of this report. Particulars as per Section 217 of the Companies Act, 1956 Information pursuant to Section 217(2A) of the Companies Act, 1956, read with Companies (Particulars of Employees) Rules, 1975, forms part of this Report. As per the provisions of Section 219 (1) (b) of the Companies Act, 1956, the Report and Accounts are being sent to the shareholders of the Company excluding the statement of particulars of employees under Section 217 (2A) of the Act. Any shareholder interested in obtaining a copy of the statement may write to the Company at the Registered Office address. Additional information on conservation of energy, technology absorption and foreign exchange earnings and outgo, as stipulated under Section 217 (1) (e) of the Companies Act, 1956 is set out in a separate statement, attached to this Report and forms part of it. Your Company has not invited/received any Fixed Deposits during the year. Human Resources The Human Resources function continued its initiatives to develop and nurture talent. The focus during the year was on enhancing employee development & motivation. Not only did this help increase productivity, but also in achieving greater customer satisfaction and lesser attrition. A series of initiatives in the area of Learning, Leadership Development and Career Planning were undertaken to enhance employee effectiveness. This has generated a lot of positive response and would be one of the drivers for growth in the coming years. In order to provide challenging working environment, personnel were relocated in existing plants / regions, based on merits and skills. Industrial Relations The industrial relations in all the units and branches of the Company remained cordial and peaceful throughout the year under review. The Company did not loose a single man-day in any of its manufacturing operations. Acknowledgment / Appreciation Your Directors place on record their gratitude to the Central Government, State Governments and Companys Bankers for the assistance, co-operation and encouragement extended to the Company. Your Directors also thank and sincerely appreciate the Dealers, Business Associates and Employees at all levels for their unstinting efforts in ensuring an excellent all round operational performance. For and on behalf of the Board Place: New Delhi (Dr. Anand C. Burman) Date:17th May, 2007 CHAIRMAN

Director’s Report